FDA fi­nal­izes CAR-T and gene ther­a­py guid­ance, of­fers sup­port for ac­cel­er­at­ed ap­provals

The FDA on Mon­day fi­nal­ized two guid­ance doc­u­ments to help spon­sors de­vel­op­ing ther­a­pies in two crowd­ed ar­eas: gene ther­a­pies us­ing genome edit­ing and ex vi­vo …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER